AcuraStem Incorporated

AcuraStem is a patient-based biotechnology company dedicated to pioneering the development of treatments for neurodegenerative diseases, specifically amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Utilizing its proprietary iNeuroRx® disease-modeling platform, the company focuses on discovering novel, effective, and broadly acting treatments that address the mechanisms driving these diseases, particularly for sporadic cases where the genetic cause is unknown.